Refine by
Drug Discovery Process Services
25 services found
Manufactured by:Molecule One sp. z o.o. based inWarszawa (Polska), POLAND
When all components of the M1 platform are deployed, along with a proprietary dataset, your entire discovery pipeline benefits. You may generate millions of compounds with high estimated synthetic accessibility, reduce reaction failure rates at the bench or automate your synthesis workflows. That enables your team to focus on more crucial discovery tasks. We can help you build a pipeline where ...
by:ProXyChem based in, MASSACHUSETTS (USA)
ProXyChem’s management, collectively, has over 40 years of drug discovery experience. We provide consulting services in all aspects of the drug discovery ...
by:PharmAI GmbH based inDresden, GERMANY
High-Throughput-Screening (HTS) is the experimental method predominantly used today in the drug discovery process. In this process, typically 50.000 to 200.000 compounds, in small containers, are screened and observed for reactions between the compounds and the ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
The drug-discovery process is a trial-and-error run and time-consuming. Currently, using in silico tools to find a molecule that binds to the target protein has made computational chemistry a valuable tool in drug ...
Manufactured by:Alfa Chemistry based inNY, NEW YORK (USA)
Nowadays, computational methods are routinely used to accelerate drug discovery process. In drug design and discovery, multiple computational chemistry approaches are employed to calculate and predict events, such as the drug binding to its target and the chemical properties for designing ...
Manufactured by:Inovotion Sas based inLa Tronche, FRANCE
Target validation is an essential and critical phase of the drug discovery process. This is a crucial step before starting to develop a treatment based on a targeted protein that has been identified to play a role in the disease. The target protein’s role must be clearly identified before starting to develop a drug ...
by:Molsoft LLC based inSan Diego, CALIFORNIA (USA)
The highly specialized research environments of life science industries require an experienced understanding of the drug discovery process. Many prescription drugs are the result of small molecules that were synthesized in large combinatorial libraries and tested ad hoc against potential targets. This random approach requires ...
Manufactured by:Alfa Chemistry based inNY, NEW YORK (USA)
Drug Discovery and Research: Alfa Chemistry aims to support efforts to generate novel drugs by serving as a one-stop platform for the variety of services and expertise needed for drug discovery and development. We will collaborate through a combination of integrated, multidisciplinary drug ...
by:Strateos Inc. based inMenlo Park, CALIFORNIA (USA)
Hit discovery or hit identification in drug development is driven by the need to identify small molecules with desirable activity in a compound screen against a target. Our state-of-the-art fully automated robotic platform is set-up to accelerate your drug discovery process starting with robust, targeted hit ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
A key step in drug discovery is target identification—identifying "druggable" biological targets. After a target is identified, it must be validated to demonstrate the functional relationship between the target and disease phenotype while ensuring safety. The drug discovery process is lengthy and costly, but good ...
by:Oncodesign based inDijon, FRANCE
Establishing proof of concept in preclinical pharmacology is a critical step in the drug discovery process. This is one of the decisive factors in setting the therapeutic indication(s) targeted in clinical models and in the decision to continue a new product through the regulatory preclinical and clinical steps. For more than 25 years, Oncodesign ...
Manufactured by:Alfa Chemistry based inNY, NEW YORK (USA)
The Alfa Chemistry platform integrates predictive methods with various computational techniques to accelerate drug discovery. Our iterative process is designed to accelerate evaluation and optimization of chemical matter in silico ahead of synthesis and assay. The most promising compounds emerging from each round of experimental project chemistry ...
by:Oncodesign based inDijon, FRANCE
DRIVE-IDDS, an integrated drug discovery solution: a complete continuum from target to clinical candidate. ...
by:PharmAI GmbH based inDresden, GERMANY
pharmAI's innovative solution, which is based on analysing the binding sites, decreases the screening space dramatically. pharmAIs algorithms provide the drug developers with predictions of one or multiple constrained compound space(s) that can easily be passed on to compound library manufacturers (for cherry ...
Manufactured by:Nexelis based inSeattle, WASHINGTON (USA)
Accelerating Drug Development Process at Scale: Nexelis, a Q² Solutions Company, utilizes automated systems for high throughput through our investment in robotics to support our scientists, who generate over 1.5 million results annually. Our immense capacity helps accelerate the drug discovery and clinical trial ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Invicro has a vast range of tools that help accelerate your drug discovery and development process. Our technology platforms support key decision-making in: Early discovery and screening. Candidate selection. First-in-human translation and early development. Late stage, multi-center determination of ...
by:Health Technology Innovations, Inc. based inPortland, OREGON (USA)
Cryo-EM is a powerful technology for determining high-resolution 3D structures of biological macromolecules and bound compounds. It is complementary to X-ray crystallography, NMR, and other biophysical ...
Manufactured by:Creative Bioarray based inShirley, NEW YORK (USA)
Compared with normal cells, tumor cells have undergone a series of genetic and epigenetic alterations that, in general, underlie cancer development, progression, and drug resistance. Tumor-derived cell lines have served as important models to advance our understanding of oncogene function and therapeutic responses. Creative Bioarray provides human tumor cells sourced from a ...
by:Strateos Inc. based inMenlo Park, CALIFORNIA (USA)
Strateos offers a wide range of off the shelf drug discovery assays and supports custom development of biochemical, biophysical and cell based assays in drug discovery, using both industry-standard and innovative technologies to support drug screening projects from hit identification to lead ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions' Discovery Services leverages the Lumin Analytic Engine and rapid validation workflows to identify novel therapeutic targets and/or biomarkers of ...